Why are CGRP monoclonal antibodies not yet the first line treatment in migraine prevention?
ABSTRACT Migraine is a prevalent disorder and a cause of high disability, influenced by modifiable and non-modifiable risk factors. Comorbid and psychiatric illnesses are prevalent in migraine patients and should be considered when choosing preventive drugs. There have been unforeseen problems with...
Збережено в:
| Автор: | |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Thieme Revinter Publicações
2022-08-01
|
| Серія: | Arquivos de Neuro-Psiquiatria |
| Предмети: | |
| Онлайн доступ: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2022000700214&tlng=en |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|